Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000431250 | SCV000513387 | benign | not specified | 2016-11-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000431250 | SCV000703137 | likely benign | not specified | 2016-11-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081134 | SCV000772532 | benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314148 | SCV000847407 | likely benign | Inborn genetic diseases | 2019-03-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000650685 | SCV001155839 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | KCNT1: BS2 |